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Abstract
Background: A control study was designed to investigate circulating Ghrelin levels in adolescent girls with
adolescent idiopathic scoliosis (AIS) and controls. Eating behavioral disorders, endocrine disorders, abnormal growth
pattern and osteopenia have been well documented in AIS. Ghrelin is an orexigenic hormone produced by the
stomach which reflects body weight changes and stimulates growth hormone secretion. Recently, it has been
shown to be associated with bone metabolism and eating behavior. However, the circulating levels of ghrelin have
never been evaluated in AIS patients.
Methods: Forty nine AIS girls and 15 controls were included. Anthropometric parameters and fasting circulating
total ghrelin were measured. Curve severity was evaluated in AIS girls. The relationships between ghrelin and age,
body weight, height, body mass index (BMI), BMI Z-score and corrected anthropometric parameters were analyzed
in AIS girls and controls.
Results: There was no significant difference in body weight, height, BMI or BMI Z-score between AIS and controls.
Serum ghrelin level was 1.8 fold higher in AIS girls than in controls. Elevation of ghrelin levels remained significant
when corrected BMI or corrected BMI Z-score were considered. Unlike in controls, positive correlations were found
between ghrelin and age in AIS girls with a gradual increase of circulating ghrelin with age.
Conclusions: We have observed significantly higher circulating ghrelin levels in AIS than in controls with a positive
correlation with age. This pilot-study suggests that ghrelin signaling might play a role in the initiation or
development of AIS. Further studies are needed to validate theses results.
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Introduction
Adolescent Idiopathic Scoliosis (AIS) is characterized by
a three-dimensional spinal deformity which occurs dur-
ing prepubertal and pubertal growth. Etiology of AIS re-
mains unknown. Hypotheses include genetic, skeletal,
muscular, biochemical, biomechanical, neurohormonal
and environmental factors [1].
A frequent characteristic of girls with AIS is that they
have significantly lower body weight and lower BMI
compared to healthy counterparts during the early and
middle pubertal stages [2–4]. Alborghetti et al. demon-
strated correlation between AIS and eating disorders [5].
Incidence of AIS patients below undernourishment de-
gree 1 or even within the margins of anorexia nervosa
(AN) is above the general population [6–8].
Ghrelin is a peptide hormone which plays a major role
in hunger stimulation. Ghrelin is secreted primarily from
the stomach. Plasma ghrelin levels are directly related to
food intake episodes. Ghrelin is secreted in a pulsated
manner as its level increases before the onset of meal,
during fasting, and decreases after a meal. This pulsatile
secretion of ghrelin suggested that ghrelin may act as a
signal for meal initiation [9]. Inverse correlations were
reported between ghrelin and BMI or fat mass [10, 11].
Studies on eating behaviors suggest that ghrelin is not
only dependent on body fat mass, but also influenced by
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Therefore, considering the low BMI and eating disor-
ders in AIS, we hypothesized that ghrelin anomaly may
be involved in scoliosis and that AIS patients may have
abnormal circulating ghrelin levels. The aim of our study
was to compare ghrelin serum level in patients with and
without AIS.
Materials and Methods
AIS patients were recruited in the Pediatric Orthopedic
Unit of our hospital. Signed informed consent was ob-
tained from the parents of all subjects. Approval was
granted by the local IRB of Toulouse University Hospital
(ID-RCB:2009-A011011-56, granted 01/19/2010). The
control group was represented by scoliosis free children
admitted in the department of surgery for various minor
elective procedures (curly toes correction, physiodesis,
or solitary osteochondroma resection), with clinical
examination and blood sampling routinely performed
before anesthesia. All subjects included in the current
study met the following criteria: no evidence of any
endocrine diseases, history of eating disorders or steroid
intake. In total, 49 AIS (12 to 17.5 years old) and 15 con-
trol Caucasian girls (12 to 17 years old) were included.
For scoliotic patients, corrected height was com-
puted by adjusting trunk loss using Bjure formula:
LogY = 0.011X - 0.177, where Y is the loss of trunk
height (cm) caused by the spinal deformity, and X is
the Cobb angle of the primary curve. Weight was mea-
sured on a digital scale in the fasting state to the near-
est 0.1 kg in normal indoor clothing and barefoot. BMI
was calculated by dividing weight (kg) by height
squared (m2) and corrected BMI (cBMI) by dividing
weight (kg) by corrected height squared (m2). BMI and
cBMI were then expressed in Z-score according to the
reference data for the French population (21).
Overnight fasting blood was obtained for ghrelin level
in both AIS patients and controls. Serum samples were
obtained after centrifugation and stored at −80 °C until
assay. At the end of the study, total ghrelin was mea-
sured using a commercial radioimmunoassay (Phoenix
Pharmaceuticals, Belmont, CA) with a detection limit at
2 pg/ml. The intra and interassay coefficients of variation
were 7.2 and 9.9 %, respectively. Data were analyzed using
STATA SE v11.0. Data reported as means ± SD. P < 0.05
was considered significant. We used Student’s t test or
Wilcoxon rank sum test to compare the two samples. Uni-
variate and multiple regression analyses were performed to
determine predictors of hormonal secretion. Square root
transformation was performed to approximate a normal
distribution for the ghrelin data. Pearson or Spearman’s
rank correlations between circulating ghrelin levels and
growth-related parameters (age, weight, height, BMI, cor-
rected height and corrected BMI) were estimated and com-
pared in AIS and controls.
Results
Clinical features of adolescents with AIS and controls are
summarized in Table 1. Wilcoxon test analysis showed
that when compared to controls, height of AIS patients
was not significantly different, but corrected height calcu-
lated with the Bjure formula showed a 5.1 centimeter dif-
ference, AIS patients being taller than controls (163.2 ± 7.3
vs 158.1 ± 10.1). This difference was close to significance
(p = 0.09). The other anthropometric parameters were not
significantly different, therefore the two groups were com-
parable. All 49 patients had at least one severe spinal curve
at the time of the blood sample, with an average Cobb
angle of 56.1 ± 13.2 degrees for the main curve. Twenty
five patients had a second curve of 54.2 ± 12.9 degrees.
We found a significantly 1.8 fold higher mean level of
total serum ghrelin in AIS group compared to the con-
trol population (261.9 ± 120.3 vs 146.1 ± 59.2; p < 0.001).
Correlations between fasting ghrelin concentrations
and age or anthropometric measurements are exhibited
in Table 2. In the control group, ghrelin revealed a
strong negative correlation with age (r = −0.60; p = 0.02).
Conversely, in the AIS group, the correlation was posi-
tive (r = 0.19; p = 0.20) and this difference of evolution
between AIS and controls was significant (p = 0.006).
Weight, height, corrected height, BMI and corrected
BMI were also moderately inversely correlated with
ghrelin levels in the control group, while they were close
to zero in the AIS group, but these correlations did not
reach statistical significance. In both groups, circulating
ghrelin correlated neither with the BMI Z-score nor
with the corrected BMI Z-score.
Discussion
Previous studies have reported lower BMI and eating dis-
orders in population of AIS. Siu et al. reported significantly
Table 1 Physical characteristics and total plasma Ghrelin level in
AIS patients and controls
AIS (n=49) Controls (n=15) p
Age (yr) 14.3 ± 1.4 13.9 ± 1.6 0.23 †
Weight (kg) 48.3± 8.0 46.9 ± 10.8 0.98 †
Height 158.8 ± 7.3 158.1 ± 10.1 0.97 †
cHeight (cm) 163.2 ± 7.3 - 0.09 †
BMI (kg/m2) 19.1 ± 2.6 18.5 ± 2.5 0.42 §
cBMI (kg/m2) 18.1 ± 2.5 - 0.61 §
BMI Z −0.02 ± 1.14 −0.16 ± 1.01 0.67 §
cBMI Z −0.46 ± 1.23 - 0.39 §
Main curve Cobb angle (°) 56.1 ± 13.2 -
2nd curve Cobb angle (n=25) 54.2 ± 12.9 -
Ghrelin (pg/mL) 261.9 ± 120.3 146.1 ± 59.2 <0.001 †
Values are shown as means ± SD. In controls, Corrected height (cHeight),
corrected BMI (cBMI), corrected BMI Z-score (cBMI Z) were equal to height, BMI,
BMI Z, of them respectively. † Wilcoxon non parametric test. § Student’s t-test
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lower body weights and BMI in AIS girls compared with
controls between the age of 12 and 15 [4]. Ramirez et al.
investigated BMI and body composition in 27 girls with
AIS and compared them to general population [6]. They
found a real alteration of body composition in AIS. The
BMI, Fatfreemass index and Fatmass index were lower
than in the general population. Smith et al. studied weight,
height and BMI in 44 young women with AIS. Compared
with normative data, patients from AIS group were signifi-
cantly lighter and had significantly lower BMI scores, 25 %
of the series had BMI scores within the definition of an-
orexia. Barrios et al. showed a progressive decrease of BMI
with age in 52 AIS girls [2]. In their study, a total of 21.2 %
of AIS girls had a BMI below 17.5 which is the threshold
for anorexia, while the incidence in the control group was
only 3.3 %.
Several studies have highlighted a significantly larger
proportion of individuals with eating disorders in AIS,
which severity was correlated with the presence of AN
[5, 8]. However, Zaina et al., using the Eat-26 question-
naire, showed a low prevalence of eating disorders in
AIS female patients [12]. They concluded that even if
low BMI individuals are more frequent in AIS, this can-
not be considered a sign of eating disorder. They attrib-
uted low BMI in AIS to hormonal alterations also
involved in the onset of scoliosis. Qiu et al. have sug-
gested that leptin plays a significant role in the patho-
genesis of AIS [13]. Leptin level is low in AIS. It has the
effect of both reducing the fat mass and altering bone
formation.
Our study suggests that inadequate secretion of
ghrelin may be involved in AIS. A 1.8 fold higher ghrelin
level was observed in the AIS group, even after control-
ling confounding factors.
Elevated ghrelin levels have been reported in AN com-
pared with normal-weighted controls [14–16]. The in-
crease of plasma ghrelin levels in AN seems paradoxical in
light of the restrained food intake of these patients and
suggests an adaptive response [17]. A state of ghrelin re-
sistance has been suspected in AN [15, 17] but also in
Prader Willi Syndrome (PWS) [18], a condition frequently
associated with scoliosis [19]. Inadequate secretion of
ghrelin may be hypothesized in AIS, associated, alike in
AN and PWS, to some degree of ghrelin resistance.
In addition to its role as the “hunger hormone”, ghrelin
plays many other roles [20]. Therefore, elevated ghrelin or
resistance may explain other abnormal findings in AIS
such as delayed puberty and bone demineralization.
A late menarche has been reported to be associated
with higher prevalence of AIS [21]. Furthermore, girls
with severe scoliosis experienced later menarche than
those with mild scoliosis [22–24]. In the general popula-
tion, a progressive decline in circulating ghrelin level
with age is observed, a phenomenon supposed to enable
puberty onset. Therefore, persistent high ghrelin level
may contribute to delay puberty in AIS patients.
Generalized reduced bone mass and osteopenia in both
axial and peripheral skeletons have been reported in AIS
[25–27]. Scoliosis causes osteopenia and osteoporosis
among girls while their siblings with normal spine remain
with normal bone mass [7].There is a decreased osteo-
genic differentiation of mesenchymal stem cell and re-
duced bone mineral density in AIS patients [28]. This can
be due to some ghrelin resistance, because ghrelin in-
creases proliferation and differentiation of osteoblasts in
vitro and bone mineral density (BMD) in vivo [29]. A var-
iety of hormones, neurotransmitters, and biologically ac-
tive substances control the functions of living bodies via
specific receptors located in cell membranes. Many of
these receptors mediate the transmission of intracellular
signals by activating guanine nucleotide-binding proteins
(G proteins) to which the receptor is coupled. Such recep-
tors are generically referred to as G protein-coupled re-
ceptors (“GPCR”s) [30]. Ghrelin secretion is stimulated by
several Gs-coupled receptors and inhibited by many Gi-
coupled and Gq receptors [31]. Given that a Gi-
signalling dysfunction has been reported in AIS [32], it
is conceivable that Gi protein hypofunctionality in AIS
could contribute to the elevation of plasma ghrelin
levels in AIS patients.
We acknowledge several weaknesses to this study.
Magnitude (Cobb angle) of scoliosis was high, up to 50°.
Nutritional as well as menstrual statuses were missing.
The small sample size as well as the unbalanced size of
the control group both decreased the power of the
study. Nonetheless, the difference of ghrelin levels be-
tween AIS and control groups was large enough to be
statistically significant. We measured only total ghrelin
Table 2 Correlations between circulating Ghrelin level and
growth related parameters in AIS patients and controls (Ghrelin
concentrations were normalized with a square root
transformation)
AIS (n=49) Control (n=15)
R p R p p†
Age (years) 0.19 0.20 −0.60 0.02 0.006
Weight (kg) 0.01 0.97 −0.31 0.26 0.31
Height (cm) −0.04 0.79 −0.35 0.21 0.32
cHeight (cm) −0.08 0.59 −0.35 0.21 0.38
BMI (kg/m2) 0.02 0.91 −0.27 0.33 0.36
cBMI (kg/m2) 0.04 0.80 −0.27 0.33 0.33
BMI Z-score −0.08 0.60 −0.07 0.81 0.98
cBMI Z-score −0.04 0.79 −0.07 0.81 0.94
R represents Pearson’s correlation coefficients for normative data. † Correlation
coefficients comparison after Fisher’s z transformation. Corrected height
(cHeight), corrected BMI (cBMI), corrected BMI Z-score (cBMI Z)
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which represents both acylated and deacylated forms.
However, only Acylated ghrelin stimulates appetite [33].
There is no population based reference data of ghrelin
level in the specific age group.
Nevertheless, these results open perspectives of fur-
ther research and if confirmed, they may have some
applications in screening and management of AIS.
Chronic central administration of ghrelin increases
bone mass through a mechanism that is independent
of body weight, suggesting that ghrelin may have a
bone anabolic effect through the central nervous sys-
tem [34]. Furthermore, ghrelin administrated intraven-
ously to human also leads to appetite increase and
food intake stimulation [35].
Conclusion
This is the first pilot-study investigating total fasting
serum ghrelin levels in AIS. The key finding was the 1.8
fold higher ghrelin levels observed in the AIS group,
even after controlling for confounding factors, suggest-
ing that ghrelin signaling might play a role in the patho-
genesis of AIS. Results need to be validated by further
studies including larger and more representative popu-
lations, with a calculation of the appropriate sample size
beforehand.
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